Voyager Therapeutics (VYGR) Misses Q4 EPS by 11c

Voyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $4.01 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
• MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c